Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Mol Neurosci. 2011 Jun 7;45(3):713–723. doi: 10.1007/s12031-011-9558-7

Table 1.

Clinical, genetic, and pathological heterogeneity in FTD

Clinical subtypes Genetic mutations Pathological subtypes
• Behavioral variant FTD TAU (coding for the microtubule associated protein tau) • Pick’s disease
• Non-fluent primary progressive aphasia PRGN (coding for progranulin) • Tau-positive FTDP-17
• semantic dementia VCP (coding for the valosin-containing protein) • TDP-43 positive FTD with or without motor neuron disease
• FTD with Parkinsonism CHMP2B (coding for the charged multivesicular protein 2B) • FUS positive
• FTD with motor neuron disease TDP (coding for the tar-DNA binding protein 43) • Progressive supranuclear palsy
• FTD with inclusion body myopathy and Paget’s disease of the bone FUS (coding for the fused in sarcoma protein) • Corticobasal degeneration
• Progressive supranuclear palsy • Unidentified gene on chromosome 9 • Ubiquitin-positive (tau/TDP43/FUS-negative) FTD
• Corticobasal degeneration